Sanuwave Health Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
SNWV
- Investments
-
7
- Share Price
-
$0.02
- (As of Friday Closing)
Sanuwave Health General Information
Description
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Contact Information
Website
www.sanuwave.com
Formerly Known As
HealthTronics (Orthopedic Electrocorporeal Shockwave Lithotripsy Assets)
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Stock Exchange
PINX
Primary Office
- 3360 Martin Farm Road
- Suite 100
- Suwanee, GA 30024
- United States
+1 (770) 000-0000
Sanuwave Health Timeline
Sanuwave Health Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $21.7M | 1.03B | 220K | -$0.06 |
Sanuwave Health Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 52,297 | 43,716 | 100,508 | 98,494 |
| Revenue | 18,116 | 16,742 | 13,010 | 4,057 |
| EBITDA | (11,113) | 4,793 | (18,900) | (27,384) |
| Net Income | (28,913) | (10,293) | (27,259) | (30,937) |
| Total Assets | 19,197 | 19,873 | 18,619 | 23,027 |
| Total Debt | 44,172 | 41,106 | 28,117 | 17,578 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sanuwave Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sanuwave Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energ
Other Devices and Supplies
Suwanee, GA
38
As of 2022
0000
000000000
0000
000000
onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
00000000000 0000000
Weßling, Germany
000
As of 0000
00000
ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000000000 000000000
Tägerwilen, Switzerland
000
As of 0000
Add Comparison
Sanuwave Health Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dornier MedTech | Corporation | Weßling, Germany | 000 | |||
| 00000 0000000 | Corporation | Tägerwilen, Switzerland | 000 | |||
| 00000000 000000 00 | Venture Capital-Backed | Kennesaw, GA | 00 | 000 | 00000 00000 | 000 |
Sanuwave Health Patents
Sanuwave Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220023607-A1 | Pressure waves for vaccines, genetic modification and medical treatments | Pending | 21-Jul-2020 | 00000000000 | 0 |
| US-20230125111-A1 | Reprocessing of contaminated reusable devices with direct contact of pressure waves | Pending | 06-May-2020 | 000000000 | 0 |
| US-20210346533-A1 | Reprocessing of medical devices that are contaminated with bacteria, viruses, other pathogens, and biofilms with shockwaves, pressure waves or ultrasound systems | Inactive | 06-May-2020 | 00000000000 | |
| US-20210308001-A1 | Shockwave and pressure waves for treatment of virus or bacteria-induced effects in human or animal lungs | Pending | 02-Apr-2020 | 000000000000 | |
| AU-2017387130-B2 | Acoustic pressure shock waves used for personalized medical treatment of tissue conditions | Active | 31-Dec-2016 | A61N7/00 | 0 |
Sanuwave Health Executive Team (12)
Sanuwave Health Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0. 000000000 | Sanuwave Health | Board Member | 000 0000 |
| 0000 000000 | Self | Board Member | 000 0000 |
| 0000 0000000 | Sanuwave Health | Board Member | 000 0000 |
| 00000 0000000000 0 | Sanuwave Health | Chief Executive Officer & Chairman | 000 0000 |
| 000-00000 0000000 | Sanuwave Health | Board Member | 000 0000 |
Sanuwave Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Sanuwave Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sanuwave Health Investments & Acquisitions (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 000000000 | 23-Aug-2023 | 0000000000 | Special Purpose Acquisition Company (SPAC) | 0. 000000 | |
| 00000 0000000 | 14-Oct-2020 | 00000 0000 | Distributors/Wholesale | 00000 000 | |
| 0000000000 (0 | 10-Aug-2020 | 000000000 | 0000 | Buildings and Property | |
| 000000000 | 07-Nov-2019 | 00000 0000 | Therapeutic Devices | 00000 000 | |
| Advance Medical Technology (FKS/Sanuwave Health) | 26-Jun-2018 | Joint Venture | Pharmaceuticals |